11/18/2026 | Press release | Distributed by Public on 11/18/2026 17:02
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (3) | 11/17/2027 | Common Stock, par value $0.01 per share | 1,837 | $99.21 | D | |
| Employee Stock Option (right to buy) | (3) | 01/29/2028 | Common Stock, par value $0.01 per share | 13,773 | $88.67 | D | |
| Employee Stock Option (right to buy) | (3) | 12/21/2028 | Common Stock, par value $0.01 per share | 20,000 | $40.4 | D | |
| Employee Stock Option (right to buy) | (3) | 03/19/2029 | Common Stock, par value $0.01 per share | 4,971 | $57.74 | D | |
| Employee Stock Option (right to buy) | (3) | 04/11/2029 | Common Stock, par value $0.01 per share | 3,229 | $51.67 | D | |
| Employee Stock Option (right to buy) | (3) | 03/02/2030 | Common Stock, par value $0.01 per share | 7,214 | $63.51 | D | |
| Employee Stock Option (right to buy) | (4) | 02/01/2033 | Common Stock, par value $0.01 per share | 6,270 | $70.01 | D | |
| Employee Stock Option (right to buy) | (5) | 03/01/2033 | Common Stock, par value $0.01 per share | 3,705 | $75.3 | D | |
| Employee Stock Option (right to buy) | (6) | 03/01/2034 | Common Stock, par value $0.01 per share | 3,067 | $92.72 | D | |
| Employee Stock Option (right to buy) | (7) | 03/03/2035 | Common Stock, par value $0.01 per share | 3,307 | $86.45 | D | |
| Employee Stock Option (right to buy) | (8) | 03/02/2036 | Common Stock, par value $0.01 per share | 3,279 | $80.16 | D | |
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Sandy Neal Joseph 500 W. MONROE STREET CHICAGO, IL 60661 |
CEO, Patient Care Solutions | |||
| /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact | 11/18/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Consists of (i) 1,758 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 775 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 381 will vest on September 3, 2027, and 394 will vest on September 3, 2028; and (iii) 1,247 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
| (2) | Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
| (3) | Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable. |
| (4) | Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable. |
| (5) | Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable. |
| (6) | Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable. |
| (7) | Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% became exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028. |
| (8) | Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
|
Remarks: Exhibit 24.1 - Power of Attorney |
|